Evidence map›Paper›PMID 27296555›Full record

ArticleScientific reports2016

Calcitonin gene-related peptide is a key factor in the homing of transplanted human MSCs to sites of spinal cord injury.

Yu Zhang, Jinhua Yang, Peng Zhang, Tao Liu, Jianwei Xu, Zhihai Fan, Yixin Shen, Wenjie Li, Huanxiang Zhang

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Nano-Anesthetics Regulate Neuro-Immune Interaction for Treating Neuropathic Pain.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Tissue Regeneration: The Dark Side of Opioids.International journal of molecular sciences · 2021
    Review
  8. Review
  9. Article
  10. Article
  11. Harnessing migraines for neural regeneration.Neural regeneration research · 2018
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yu ZhangDepartment of Orthopedics, the Second Affiliated Hospital of Soochow University, Suzhou, China.
Jinhua YangDepartment of Orthopedics, the Second People's Hospital of Changshu, Suzhou, China.
Peng ZhangDepartment of Orthopedics, the Second Affiliated Hospital of Soochow University, Suzhou, China.
Tao LiuDepartment of Orthopedics, the Second Affiliated Hospital of Soochow University, Suzhou, China.
Jianwei XuDepartment of Cell Biology, Jiangsu Key Laboratory of Stem Cell Research, Medical College of Soochow University, Suzhou Industrial Park, Suzhou, China.
Zhihai FanDepartment of Orthopedics, the Second Affiliated Hospital of Soochow University, Suzhou, China.
Yixin ShenDepartment of Orthopedics, the Second Affiliated Hospital of Soochow University, Suzhou, China.
Wenjie LiDepartment of Human Anatomy, Medical College of Soochow University, Suzhou Industrial Park, Suzhou, China.
Huanxiang ZhangDepartment of Cell Biology, Jiangsu Key Laboratory of Stem Cell Research, Medical College of Soochow University, Suzhou Industrial Park, Suzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) can be used to treat many diseases, including spinal cord injury (SCI). Treatment relies mostly on the precise navigation of cells to the injury site for rebuilding the damaged spinal cord. However, the key factors guiding MSCs to the epicenter of SCI remain unknown. Here, we demonstrated that calcitonin gene-related peptide (CGRP), a neural peptide synthesized in spinal cord, can dramatically aid the homing of human umbilical cord mesenchymal stem cells (HUMSCs) in spinal cord-transected SCI rats. First, HUMSCs exhibited chemotactic responses in vitro to CGRP. By time-lapse video analysis, increased chemotactic index (CMI), forward migration index (FMI) and speed contributed to this observed migration. Then, through enzyme immunoassay, higher CGRP concentrations at the lesion site were observed after injury. The release of CGRP directed HUMSCs to the injury site, which was suppressed by CGRP 8-37, a CGRP antagonist. We also verified that the PI3K/Akt and p38MAPK signaling pathways played a critical role in the CGRP-induced chemotactic migration of HUMSCs. Collectively, our data reveal that CGRP is a key chemokine that helps HUMSCs migrate to the lesion site and thereby can be used as a model molecule to study MSCs homing after SCI.

Indexed as

Mesenchymal Stem Cell TransplantationAnimalsApoptosisCalcitonin Gene-Related PeptideCell ProliferationCell ShapeChemotaxisFemaleHumansImmunohistochemistryMesenchymal Stem CellsMitogen-Activated Protein KinasesPhosphatidylinositol 3-KinasesProtein Kinase InhibitorsProto-Oncogene Proteins c-aktRats, Sprague-DawleyCalcitonin Gene-Related PeptideMitogen-Activated Protein KinasesPhosphatidylinositol 3-KinasesProtein Kinase InhibitorsProto-Oncogene Proteins c-akt

Identifiers

PMID27296555
PMCPMC4906351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.